Tenkanen, L <br/><br/>
Some coronary risk factors related to the insulin resistance syndrome and treatment with gemfibrozil. Experience from the Helsinki Heart Study.  [electronic resource] 

 -  Circulation  Oct 1995 
 - 1779-85 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0009-7322 
<br/><br/><label>Standard No.: </label>10.1161/01.cir.92.7.1779  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Blood Glucose--analysis<br/>Body Mass Index<br/>Cholesterol, HDL--blood<br/>Coronary Disease--epidemiology<br/>Double-Blind Method<br/>Gemfibrozil--therapeutic use<br/>Humans<br/>Hypercholesterolemia--drug therapy<br/>Hypolipidemic Agents--therapeutic use<br/>Incidence<br/>Insulin Resistance<br/>Male<br/>Middle Aged<br/>Obesity--epidemiology<br/>Proportional Hazards Models<br/>Smoking--epidemiology<br/>Triglycerides--blood